Brian M. Stolz
Overview
Brian M. Stolz received an average of $4M in total compensation, including $421K in salary, at Valeant Pharmaceuticals International from 2011 to 2015.
2015Valeant Pharmaceuticals InternationalSenior Vice President and General Manager
2014Valeant Pharmaceuticals InternationalSenior Vice President and General Manager
2013Valeant Pharmaceuticals InternationalSenior Vice President and General Manager
2011Valeant Pharmaceuticals InternationalExecutive Vice President of Administration and Chief Human Capital Officer
Source: SEC filings on April 29, 2016 and April 30, 2012.
Related executives
We found 27 more executives who work or worked at Valeant Pharmaceuticals International.
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
Sam Eldessouky
Valeant Pharmaceuticals International
Chief Financial Officer
Robert Spurr
Valeant Pharmaceuticals International
President, U.S. Pharma Business
Joseph Gordon
Valeant Pharmaceuticals International
President & Co, Head, Bausch + Lomb/International
William Humphries
Valeant Pharmaceuticals International